Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 3
1993 5
1994 39
1995 75
1996 130
1997 101
1998 92
1999 192
2000 201
2001 301
2002 483
2003 647
2004 748
2005 860
2006 860
2007 1044
2008 1203
2009 1287
2010 1407
2011 1448
2012 1650
2013 1754
2014 1528
2015 1531
2016 1794
2017 1894
2018 1844
2019 701
2020 10
Text availability
Article attribute
Article type
Publication date

Search Results

20,830 results
Results by year
Filters applied: . Clear all
Page 1
Cell-based therapeutic strategies for multiple sclerosis.
Scolding NJ, et al. Brain 2017 - Review. PMID 29053779 Free PMC article.
Cell-based therapies, including immunoablation followed by autologous haematopoietic stem cell transplantation, mesenchymal and related stem cell transplantation, pharmacologic manipulation of endogenous stem cells to enhance their reparative capabilities, and transplantation of oligodendrocyte progenitor cells, have generated substantial interest as novel therapeutic strategies for immune modulation, neuroprotection, or repair of the damaged central nervous system in multiple sclerosis. ...Moreover, clinical trials of cell-based therapies present several unique methodological and ethical issues. We summarize here the status of cell-based therapies to treat multiple sclerosis and make consensus recommendations for future research and clinical trials....
Cell-based therapies, including immunoablation followed by autologous haematopoietic stem cell transplantation, mesench
Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies.
Chabannon C, et al. Sci Transl Med 2018 - Review. PMID 29643233
Improved understanding of underlying biological processes resulted in the design of innovative therapies engineered from defined cell populations and testing of these therapies as addition or substitution at virtually every step of the procedure. This review provides an overview of these developments, many of them now applied outside the historical field of hematopoietic cell transplantation....
Improved understanding of underlying biological processes resulted in the design of innovative therapies engineered from defined cell
Haploidentical stem cell transplantation-bone marrow vs peripheral blood.
Gulbas Z. Transfus Apher Sci 2018 - Review. PMID 29764770
Hematopoietic stem cells may be obtained by collection of bone marrow, mobilization and collection of peripheral blood stem cells or umbilical cord blood. ...We reviewed the question of which stem cell source - bone marrow (BM) or peripheral blood (PBSC) - is the most suitable for individuals undergoing haploidentical stem cell transplantation. ...
Hematopoietic stem cells may be obtained by collection of bone marrow, mobilization and collection of peripheral blood stem ce …
The role of physical rehabilitation in stem cell transplantation patients.
Steinberg A, et al. Support Care Cancer 2015 - Review. PMID 25971213 Free PMC article.
The purpose of this paper is to review the evidence for the role of physical rehabilitation in stem cell transplantation patients. We will also review the literature and discuss professional experiences on how rehabilitation can play a role in stem cell transplant care and survivorship. ...
The purpose of this paper is to review the evidence for the role of physical rehabilitation in stem cell transplantation patie …
Progress of Stem Cell Transplantation for Treating Myocardial Infarction.
Chen Z, et al. Curr Stem Cell Res Ther 2017 - Review. PMID 28969536
OBJECTIVE: To summarize the recent advance of stem cell transplantation for treating MI in clinical trials and preclinical studies. ...CONCLUSION: Stem cell transplantation for treating MI in clinical trials has achieved modest therapeutic effect. The hurdles limiting the stem cell function define the direction of further research....
OBJECTIVE: To summarize the recent advance of stem cell transplantation for treating MI in clinical trials and preclinical stu …
Hematopoietic Stem Cell Transplantation in Crohn's Disease: State-of-the-Art Treatment.
Hawkey CJ. Dig Dis 2017 - Review. PMID 28147358
Both autologous and allogeneic haemopoietic stem cell transplantation (HSCT) have been tried in Crohn's disease (CD). In allogeneic HSCT, the host bone marrow is ablated and replaced by bone marrow from a donor. ...In autologous HSCT, the patient's own stem cells are harvested before proceeding to lymphoablation and transplantation of the patient's own uncommitted stem cells, which generate an immune system with an altered T-cell repertoire. ...
Both autologous and allogeneic haemopoietic stem cell transplantation (HSCT) have been tried in Crohn's disease (CD). In allog …
20,830 results
Jump to page
Feedback